Used as an intermediate in the synthesis of beta-adrenergic blocking agents, particularly in the production of atenolol and related cardiovascular drugs. Its structure supports the creation of selective beta-1 receptor antagonists, which are widely prescribed for hypertension, angina, and arrhythmias. The compound’s functional groups allow for efficient coupling and modification in multi-step pharmaceutical syntheses. It is valued in industrial drug manufacturing for its reactivity and specificity in forming active pharmaceutical ingredients.